After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
Stocks Info
Janux Therapeutics Inc is listed on the NASDAQ as a member of the Healthcare sector and is a part of the Biotechnology industry. The current market capitalization of Janux Therapeutics Inc is $1.77B. A total of 0.73 million shares were traded on the day, compared to an average of 942.12K shares.
In the most recent transaction, ANDREW MEYER bought 3,334 shares of JANX for 29.69 per share on Apr 21 ’25. In a previous transaction on Mar 06 ’25, RA CAPITAL MANAGEMENT, L.P. bought 372,093 shares at 30.78 per share. JANX shares that Director owns now total 10,031,081.
Among the insiders who bought shares, RA CAPITAL MANAGEMENT, L.P. acquired of 341,742 shares on Mar 05 ’25 at a per-share price of $30.64. This resulted in the Director holding 9,658,988 shares of JANX after the transaction. In another insider transaction, RA CAPITAL MANAGEMENT, L.P. bought 110,206 shares at $31.02 per share on Mar 07 ’25. Company shares held by the Director now total 10,141,287.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, JANX has a high of $71.71 and a low of $22.52.
As of this writing, JANX has an earnings estimate of -$0.39 per share for the current quarter. EPS was calculated based on a consensus of 6.0 estimates, with a high estimate of -$0.31 per share and a lower estimate of -$0.48.
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. JANX’s latest balance sheet shows that the firm has $374.96M in Cash & Short Term Investments as of fiscal 2021. There were $194.00k in debt and $12.80M in liabilities at the time. Its Book Value Per Share was $17.32, while its Total Shareholder’s Equity was $366.33M.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for JANX is Buy with a score of 4.82.
